CeriBell, Inc (CBLL) Key Metrics
CBLL valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $961.0M
- Enterprise value
- $799.2M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 9.4
- Price / book
- 7.1
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.93
CBLL key metrics, 2022–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCBLL valuation Price multiples at each fiscal year-end price.
CBLL returns How much profit the business earns on the capital it uses.
CBLL per-share figures Results divided by the shares outstanding at year-end.
CBLL financial health Debt, liquidity and how easily interest is covered.
CBLL efficiency & capital use Working capital cycle and where the cash goes.
CBLL valuation history
CBLL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CBLL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CBLL cash returned to shareholders
CBLL price vs earnings per share
CBLL key metrics
2022–2025| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Valuation | ||||
| Market capitalization | $801.4M | $927.8M | — | — |
| Enterprise value | $664.4M | $755.4M | — | — |
| Price / sales | 9.0 | 14.2 | — | — |
| Price / book | 5.2 | 4.9 | — | — |
| EV / sales | 7.5 | 11.5 | — | — |
| Earnings yield | −6.7% | −4.4% | — | — |
| Free cash flow yield | −5.2% | −3.9% | — | — |
| Share price at fiscal year-end | $21.93 | $25.88 | — | — |
| Per share | ||||
| Revenue per share | $2.44 | $1.83 | $1.94 | $1.11 |
| Earnings per share | −$1.46 | −$1.13 | −$1.26 | −$1.59 |
| Operating cash flow per share | −$1.12 | −$0.98 | −$1.25 | −$1.37 |
| Free cash flow per share | −$1.14 | −$1.01 | −$1.29 | −$1.39 |
| Cash per share | $4.36 | $5.42 | $1.48 | $2.93 |
| Book value per share | $4.25 | $5.33 | −$4.81 | −$3.70 |
| Tangible book value per share | $4.23 | $5.32 | −$4.81 | −$3.70 |
| Capex per share | $0.02 | $0.04 | $0.04 | $0.02 |
| Debt per share | $0.61 | $0.61 | $0.61 | $0.78 |
| Shares outstanding | 36.5M | 35.9M | 23.3M | 23.3M |
| Change in shares outstanding | +1.9% | +53.7% | 0.0% | — |
| Returns & profitability | ||||
| Return on equity (ROE) | −30.8% | −102.5% | — | — |
| Return on invested capital (ROIC) | −248.7% | — | — | — |
| Return on assets (ROA) | −25.4% | −28.5% | −40.5% | −43.0% |
| Return on tangible assets | −27.4% | −18.0% | −50.0% | −43.0% |
| Free cash flow margin | −46.7% | −55.6% | −66.6% | −125.4% |
| Financial health | ||||
| Total debt | $22.3M | $22.0M | $14.2M | $18.2M |
| Cash & short-term investments | $159.3M | $194.4M | $34.5M | $68.2M |
| Net debt | −$137.0M | −$172.4M | −$20.3M | −$50.0M |
| Debt / equity | 0.14 | 0.11 | — | — |
| Debt / assets | 0.11 | 0.10 | 0.24 | 0.21 |
| Current ratio | 9.73 | 16.73 | 2.41 | 8.09 |
| Quick ratio | 9.35 | 16.19 | 2.13 | 7.68 |
| Interest coverage | -30.9 | -19.9 | -14.3 | -22.5 |
| Working capital | $167.5M | $204.3M | $30.4M | $69.9M |
| Invested capital | $18.4M | $18.8M | −$132.5M | −$136.4M |
| Tangible asset value | $154.5M | $190.7M | −$112.3M | −$86.4M |
| Net current asset value | $146.3M | $183.0M | −$119.2M | −$93.1M |
| Graham net-net per share | $3.66 | $4.79 | −$5.48 | −$4.23 |
| Capital allocation | ||||
| Share buybacks (net) | — | — | $0 | $310,000 |
| Capex / revenue | 0.9% | 2.0% | 2.2% | 2.0% |
| Capex / depreciation | 0.57 | 1.17 | 1.16 | 1.04 |
| Stock-based compensation / revenue | 13.7% | 8.3% | 5.9% | 30.6% |
| R&D / revenue | 21.5% | 20.7% | 19.9% | 27.9% |
| SG&A / revenue | 132.0% | 126.7% | 130.9% | 193.9% |
| Efficiency | ||||
| Days sales outstanding | 53.1 | 52.5 | 53.5 | 74.6 |
| Days of inventory on hand | 240.6 | 268.8 | 257.0 | 335.8 |
| Days payables outstanding | 67.3 | 39.4 | 29.8 | 34.9 |
| Cash conversion cycle (days) | 226.4 | 282.0 | 280.6 | 375.5 |
| Receivables turnover | 6.87 | 6.95 | 6.83 | 4.90 |
| Payables turnover | 5.42 | 9.27 | 12.23 | 10.47 |
| Inventory turnover | 1.52 | 1.36 | 1.42 | 1.09 |
| Asset turnover | 0.42 | 0.46 | 0.62 | 0.30 |
| Average receivables | $13.0M | $9.4M | $6.6M | $5.3M |
| Average payables | $2.0M | $937,500 | $577,500 | $423,000 |
| Average inventory | $7.1M | $6.4M | $5.0M | $4.1M |
| Intangibles / total assets | 0.4% | 0.2% | 0.0% | 0.0% |
Computed from CBLL's annual financial statements (latest annual report filed February 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CBLL valuation and financial ratios
CeriBell earned a return on equity of −30.8% and a return on invested capital of −248.7% in fiscal 2025. It ended the year with $22.3 million of debt and $159.3 million in cash and short-term investments, a net cash position of $137.0 million.
See the CBLL income statement, the CBLL chart for price history, or the CBLL stock overview for the latest quote and news.
CBLL key metrics FAQ
What is CeriBell's return on equity?
CeriBell's return on equity (ROE) was −30.8% in fiscal 2025: net income of -$53.4 million on average shareholders' equity of $173.3 million.
What is CeriBell's ROIC?
CeriBell's return on invested capital was −248.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does CeriBell have?
CeriBell had total debt of $22.3 million at the end of fiscal 2025, a debt-to-equity ratio of 0.14 and more cash than debt.
What is CeriBell's free cash flow yield?
CeriBell generated -$41.6 million of free cash flow in fiscal 2025, a free cash flow yield of −5.2% on its market value at year-end ($801.4 million).
What is CeriBell's current ratio?
CeriBell's current ratio was 9.73 at the end of fiscal 2025: current assets were 9.73 times current liabilities.